Trademark: 87108421
Word
EMTORLIF
Status
Dead
Status Code
606
Status Date
Monday, August 12, 2019
Serial Number
87108421
Mark Type
4000
Filing Date
Tuesday, July 19, 2016
Published for Opposition
Tuesday, November 15, 2016
Abandoned Date
Monday, August 12, 2019

Trademark Owner History
Novartis AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Aug 12, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 12, 2019
Abandonment - No Use Statement Filed
Jan 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2019
Extension 4 Granted
Jan 9, 2019
Extension 4 Filed
Jan 9, 2019
Teas Extension Received
Jul 10, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 7, 2018
Extension 3 Granted
Jul 7, 2018
Extension 3 Filed
Jul 7, 2018
Teas Extension Received
Jan 11, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 9, 2018
Extension 2 Granted
Jan 9, 2018
Extension 2 Filed
Jan 9, 2018
Teas Extension Received
Jul 4, 2017
Notice Of Approval Of Extension Request E-Mailed
Jul 2, 2017
Extension 1 Granted
Jul 2, 2017
Extension 1 Filed
Jul 2, 2017
Teas Extension Received
Jan 10, 2017
Noa E-Mailed - Sou Required From Applicant
Nov 15, 2016
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2016
Published For Opposition
Oct 26, 2016
Notification Of Notice Of Publication E-Mailed
Oct 4, 2016
Approved For Pub - Principal Register
Sep 27, 2016
Assigned To Examiner
Jul 22, 2016
New Application Office Supplied Data Entered In Tram
Jul 22, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24